• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物肠上皮细胞加合物:大鼠双氯芬酸肠病的可能病因

Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats.

作者信息

Atchison C R, West A B, Balakumaran A, Hargus S J, Pohl L R, Daiker D H, Aronson J F, Hoffmann W E, Shipp B K, Treinen-Moslen M

机构信息

Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

出版信息

Gastroenterology. 2000 Dec;119(6):1537-47. doi: 10.1053/gast.2000.20186.

DOI:10.1053/gast.2000.20186
PMID:11113075
Abstract

BACKGROUND & AIMS: Enteropathy is a frequent complication of diclofenac and other nonsteroidal anti-inflammatory drugs, yet little is known about the underlying mechanism. One possibility is that reactive metabolites of diclofenac form adducts with enterocyte macromolecules, as previously shown for liver. We addressed this possibility by using immunohistochemistry to detect diclofenac adducts.

METHODS

Rats were treated orally with diclofenac (10-100 mg/kg) and killed after 1-24 hours, and their gastrointestinal (GI) tracts were evaluated for ulcer number and area. Adduct distribution and intensity were assessed by immunohistochemistry by using a technique to simultaneously process and stain multiple intestinal rings.

RESULTS

Drug treatment led to dose-dependent formation of both adducts and ulcers only in small intestine and only in animals with intact enterohepatic circulation. Adducts formed within enterocytes by 1 hour, translocated to the brush border, preceded ulceration and vascular protein leakage, and were intense at sites of ulceration. Adducts and ulcers exhibited a parallel distribution within intestinal quintiles: 3rd > 5th >> 1st.

CONCLUSIONS

Diclofenac treatment resulted in the formation of drug adducts in enterocytes. Because this molecular change occurred before ulceration, was dose dependent, and exhibited concordant distribution with extent of ulceration, the results suggest a causal role for drug adduct formation in diclofenac enteropathy.

摘要

背景与目的

肠病是双氯芬酸及其他非甾体抗炎药常见的并发症,但其潜在机制尚不清楚。一种可能性是双氯芬酸的反应性代谢产物与肠上皮细胞大分子形成加合物,如先前在肝脏中所显示的那样。我们通过免疫组织化学检测双氯芬酸加合物来探讨这种可能性。

方法

给大鼠口服双氯芬酸(10 - 100mg/kg),1 - 24小时后处死,评估其胃肠道的溃疡数量和面积。采用同时处理和染色多个肠环的技术,通过免疫组织化学评估加合物的分布和强度。

结果

药物治疗仅在小肠且仅在肝肠循环完整的动物中导致加合物和溃疡的剂量依赖性形成。加合物在1小时内在肠上皮细胞内形成,转移至刷状缘,先于溃疡和血管蛋白渗漏出现,且在溃疡部位强烈。加合物和溃疡在肠段五分位数内呈现平行分布:第3段>第5段>>第1段。

结论

双氯芬酸治疗导致肠上皮细胞中药物加合物的形成。由于这种分子变化在溃疡形成之前发生,具有剂量依赖性,且与溃疡程度呈现一致分布,结果表明药物加合物形成在双氯芬酸肠病中起因果作用。

相似文献

1
Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats.药物肠上皮细胞加合物:大鼠双氯芬酸肠病的可能病因
Gastroenterology. 2000 Dec;119(6):1537-47. doi: 10.1053/gast.2000.20186.
2
Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats.双氯芬酸酰基葡萄糖醛酸苷是一种主要的胆汁代谢产物,直接参与大鼠小肠损伤过程。
Gastroenterology. 1998 Dec;115(6):1476-82. doi: 10.1016/s0016-5085(98)70026-5.
3
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.环丙沙星阻断了双氯芬酸的肠肝循环,并部分通过抑制肠道β-葡萄糖醛酸酶活性减轻了大鼠非甾体抗炎药诱导的肠病。
Acta Pharmacol Sin. 2016 Jul;37(7):1002-12. doi: 10.1038/aps.2016.54. Epub 2016 May 16.
4
Aging enhances susceptibility of diclofenac-treated rats to gastric ulceration, while attenuating enteropathy.衰老增强了双氯芬酸处理的大鼠对胃溃疡的易感性,同时减轻了肠道病变。
Dig Dis Sci. 2000 Mar;45(3):614-20. doi: 10.1023/a:1005422029918.
5
Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.药物靶向或遗传敲除线粒体亲环素 D 可预防 NSAID 诱导的小鼠小肠溃疡。
Toxicol Sci. 2010 Nov;118(1):276-85. doi: 10.1093/toxsci/kfq226. Epub 2010 Jul 28.
6
Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy.通过 JNK 抑制剂 SP600125 预防 NSAID 相关肠病小鼠模型中的双氯芬酸诱导的小肠损伤。
Am J Physiol Gastrointest Liver Physiol. 2009 Nov;297(5):G990-8. doi: 10.1152/ajpgi.00219.2009.
7
Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions.双氯芬酸在大鼠小肠中蛋白质加合物的免疫化学检测与鉴定:在过敏反应中的可能作用
Chem Res Toxicol. 1998 Mar;11(3):164-71. doi: 10.1021/tx970182j.
8
Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine.肠道细胞色素 P450 酶在双氯芬酸诱导的小肠毒性中的作用。
J Pharmacol Exp Ther. 2012 Nov;343(2):362-70. doi: 10.1124/jpet.112.198077. Epub 2012 Aug 14.
9
Distribution of small intestinal mucosal injuries as a result of NSAID administration.非甾体抗炎药导致的小肠黏膜损伤分布情况。
Eur J Clin Invest. 2010 Jun;40(6):504-10. doi: 10.1111/j.1365-2362.2010.02290.x. Epub 2010 Apr 14.
10
Pathogenesis of diclofenac enteropathy.双氯芬酸肠病的发病机制。
Gastroenterology. 2001 Jun;120(7):1885; author reply 1886-7. doi: 10.1053/gast.2001.25307.

引用本文的文献

1
Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy.人肠道类器官:预测口服药物处置、毒性和疗效的非临床应用。
Pharmacol Ther. 2025 May 19:108879. doi: 10.1016/j.pharmthera.2025.108879.
2
Interlaboratory comparison of an intestinal triple culture to confirm transferability and reproducibility.肠道三联培养物的实验室间比较以确认可转移性和可重复性。
In Vitro Model. 2022 Jun 13;2(3-4):89-97. doi: 10.1007/s44164-022-00025-w. eCollection 2023 Aug.
3
Glycomacropeptide Ameliorates Indomethacin-Induced Enteropathy in Rats by Modifying Intestinal Inflammation and Oxidative Stress.
糖巨肽通过调节肠道炎症和氧化应激改善哚美辛诱导的大鼠肠病。
Molecules. 2020 May 18;25(10):2351. doi: 10.3390/molecules25102351.
4
Identification and Characterization of Efflux Transporters That Modulate the Subtoxic Disposition of Diclofenac and Its Metabolites.鉴定和表征调节双氯芬酸及其代谢物亚毒处置的外排转运体。
Drug Metab Dispos. 2019 Oct;47(10):1080-1092. doi: 10.1124/dmd.119.086603. Epub 2019 Aug 9.
5
Experimental study of diclofenac and its biliary metabolites on anastomotic healing.双氯芬酸及其胆汁代谢产物对吻合口愈合的实验研究
BJS Open. 2018 May 17;2(4):220-228. doi: 10.1002/bjs5.63. eCollection 2018 Aug.
6
Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak in Rats.微生物葡萄糖醛酸酶抑制可减轻双氯芬酸诱导的大鼠吻合口漏的严重程度。
Surg Infect (Larchmt). 2018 May/Jun;19(4):417-423. doi: 10.1089/sur.2017.245. Epub 2018 Apr 6.
7
Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.环丙沙星阻断了双氯芬酸的肠肝循环,并部分通过抑制肠道β-葡萄糖醛酸酶活性减轻了大鼠非甾体抗炎药诱导的肠病。
Acta Pharmacol Sin. 2016 Jul;37(7):1002-12. doi: 10.1038/aps.2016.54. Epub 2016 May 16.
8
Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity.阐明活性代谢物双氯芬酸酰基葡萄糖醛酸介导毒性的机制。
J Pharmacol Exp Ther. 2016 Apr;357(1):167-76. doi: 10.1124/jpet.115.230755. Epub 2016 Feb 11.
9
Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.多药耐药相关蛋白3在抵御双氯芬酸急性毒性中起重要作用。
Drug Metab Dispos. 2015 Jul;43(7):944-50. doi: 10.1124/dmd.114.061705. Epub 2015 Apr 20.
10
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.非甾体抗炎药相关性肠病的发病机制、预防及临床意义。
World J Gastroenterol. 2013 Mar 28;19(12):1861-76. doi: 10.3748/wjg.v19.i12.1861.